Incyte Corporation (LON:0J9P)
99.50
+0.83 (0.85%)
Dec 30, 2025, 12:16 PM BST
Incyte Employees
Incyte had 2,617 employees as of December 31, 2024. The number of employees increased by 93 or 3.68% compared to the previous year.
Employees
2,617
Change (1Y)
93
Growth (1Y)
3.68%
Revenue / Employee
1.37M GBP
Profits / Employee
337.88K GBP
Market Cap
14.45B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,617 | 93 | 3.68% |
| Dec 31, 2023 | 2,524 | 200 | 8.61% |
| Dec 31, 2022 | 2,324 | 230 | 10.98% |
| Dec 31, 2021 | 2,094 | 321 | 18.10% |
| Dec 31, 2020 | 1,773 | 317 | 21.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Convatec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
| HUTCHMED (China) | 1,811 |
Incyte News
- 7 days ago - Incyte Secures Dual Approvals In Japan For Zynyz And Minjuvi - Nasdaq
- 7 days ago - Incyte (INCY) Soars 5.5%: Is Further Upside Left in the Stock? - Nasdaq
- 8 days ago - Japan Approves Incyte's (INCY) Zynyz for First-Line SCAC Treatment - GuruFocus
- 8 days ago - Incyte (INCY) Secures Japanese Approval for Minjuvi Combination Therapy - GuruFocus
- 8 days ago - Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma - Business Wire
- 8 days ago - Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer - Business Wire
- 11 days ago - EC Approves Label Expansion of INCY's Lymphoma Drug Minjuvi - Nasdaq
- 11 days ago - Best Defensive Stocks To Balance Tech Sector Volatility - Seeking Alpha